Tune in as the IMF brings myeloma support group leaders and patients to the hybrid 64th annual meeting of the American Society of Hematology (ASH), an exciting convergence of 10,000 health care professionals from around the world. Start following the IMF ASH team members now on social media as they ramp up to share the latest clinical updates in myeloma research, therapies, and practice strategies via Twitter (#ASH22 and #IMFASH22), Facebook, blogs, and videos.

The IMF’s utmost concern is always focused on patient’s health. With this year’s ASH meeting being hybrid, the IMF provided the option to support group leaders to attend ASH in person or virtually. The #IMFASH22 leaders team will consist of eight leaders attending in person and five leaders attending virtually as indicated below their photos.

We thank these leaders for their care and commitment in sharing their experience with the global myeloma community. We encourage you to read and follow these leaders for their unique perspectives.

Social Media Team

Jack Aiello

Jack Aiello

Diagnosed with myeloma in 1995, Jack is strong proponent of patients participating in clinical trials so that, in the future, myeloma and other cancers will be known as curable diseases. He is a proud facilitator of the San Francisco Bay Area Myeloma Support Group.

Jack Aiello
(virtual)

Follow Jack on Twitter:
@JackMAiello
Read Blog Posts

Sheri Baker

Sheri Baker

Since being diagnosed in 2011, Sheri had a desire to help other patients & caregivers. She started the Treasure Valley Multiple Myeloma support group in Boise, Idaho in 2017. Sheri will be attending the ASH Annual Meeting for the second time.

Sheri Baker
(in-person)

Follow Sheri on Twitter:
@blondie1746
Read Blog Posts

Becky Bosley

Becky Bosley

Becky is the proud facilitator of the Mid Atlantic Myeloma Support and Information Group, based out of the Baltimore, Maryland area. Becky has spent her entire professional career as an oncology nurse, achieving her OCN certification in 2015, working as an inpatient oncology nurse, and most recently, serving as a Cellular Therapy and Transplant Nurse Coordinator at University of Maryland Medical Center. She is excited to attend ASH for the first time as a correspondent with the IMF.

Becky Bosley
(virtual)

Follow Becky on Twitter:
@MidAtlanticMSG
Read Blog Posts

Jessie Daw

Jessie Daw

Jessie was diagnosed with smoldering multiple myeloma in 2016, after several frequent bouts of respiratory infections. She has considered clinical trials, but thus far, has stayed with a “watch and wait” approach. She is a co-founder and leader of  the Eastern South Dakota Multiple Myeloma Support Group. This is Jessie’s first time attending ASH.

Jessie Daw
(virtual)

Follow Jessie on Twitter:
@Daw6Jessie
Read Blog Posts

John DeFlice

John DeFlice

John DeFlice, M.D. is a ten-year multiple myeloma survivor. He had a stem cell transplant at Cedars-Sinai Samuel Oschin Cancer Center in Los Angeles in 2011and is currently on maintenance therapy. John is a co-lead of the International Myeloma Foundation support group in Santa Fe, New Mexico, and has attended ASH at the invitation of the IMF for four years. He will again be participating in the virtual ASH 2021. 

John DeFlice
(in-person)

Follow John on Twitter:
@JohnDe1MYELOMA
Read Blog Posts

Linda Huguelet

Linda Huguelet

Diagnosed with multiple myeloma in April 2010 at the young age of 46, Linda Huguelet has been co-leading the Chattanooga Multiple Myeloma Networking group alongside her husband since February 2011. Excited to learn of the latest developments in myeloma care, Linda will be attending ASH for the eighth time with the IMF.

Linda Huguelet
(in-person)

Follow Linda on Twitter:
@LindaMYELOMA
Read Blog Posts

Diane Hunter

Diane Hunter

Diane Hunter
(in-person)

Follow Diane on Twitter:
@DianeHunterMM
Read Blog Posts

Nick Lenoir

Nick Lenoir

Nick Lenoir
(in-person)

Follow Nick on Twitter:
@MMyelomaLiving
Read Blog Posts

Gail McCray

Gail McCray

Gail McCray
(virtual)

Follow Gail on Twitter:
@IMFgailMYELOMA
Read Blog Posts

Teresa Miceli

Teresa Miceli

Ms. Miceli is a 28-year nurse veteran in the area of Blood and Marrow Transplantation. Her current role is that of a BMT RN Care Coordinator for the Adult Program at Mayo Clinic-Rochester, MN. Ms. Miceli is a charter member of the Nurse Leadership Board of the International Myeloma Foundation. She is the facilitator of the Multiple Myeloma Sharing Sessions in Rochester, MN, a support group for myeloma survivors and caregivers.

Teresa Miceli
(in-person)

Follow Teresa on Twitter:
@IMFnurseMYELOMA
Read Blog Posts

Michael Tuohy

Michael Tuohy

Michael Tuohy was diagnosed with multiple myeloma in 2000 when he was 36 years old. With two young children (ages 2 and 7) the focus was always on finding the best treatment options, and beating myeloma. His approach over the years has been to become empowered by learning as much as he could to have productive conversations with his doctors, and to then share his experience with others to help them along their own journey. 

Michael Tuohy
(in-person)

Follow Michael on Twitter:
@IMFmikeMYELOMA
Read Blog Posts

Robin Tuohy

Robin Tuohy

Robin Tuohy became a passionate advocate in the myeloma world in 2000 when her husband, Michael was diagnosed. In 2005 she began working for the International Myeloma Foundation, and is now Vice President Support Groups. She leads the IMF’s Support Group team and oversees approximately 160 U.S. myeloma specific support groups. Robin and her husband, Michael also founded and co-lead the Connecticut Multiple Myeloma Fighters Information Group.

Robin Tuohy
(in-person)

Follow Robin on Twitter:
@IMFSupport
Read Blog Posts

Jill Zitzewitz

Jill Zitzewitz

Jill Zitzewitz, PhD is an associate professor in academic medicine, where she has spent her career studying therapeutic development for protein misfolding diseases. Since being diagnosed with multiple myeloma in 2017, Jill has transitioned to a fully educational role, teaching medical and graduate students and using her experience with multiple myeloma to provide the patient perspective to our future doctors and scientists.

Jill Zitzewitz
(virtual)

Follow Jill on Twitter:
@JillZitzewitz
Read Blog Posts

hand reaching for sunset

A Message of Hope and Healing

My attendance at the 64th Annual Society of Hematology Annual Meeting, in New Orleans, LA, 12/9-12/2022 was an amazing experience. As a first-time attendee, I was at times overwhelmed because the target audience for the information presented was medical professionals,...
megaphone in hand

The Power of Your Voice

My first visit to the 64th American Society of Hematology Annual Meeting Exhibit Hall was impressive. A conversation with Darrin Gansebom at the Takeda Oncology booth was a highlight. Teresa Miceli and I introduced ourselves and expressed our gratitude for Takeda...
red traffic light

When to Stop Maintenance

I am a five-year multiple myeloma (MM) survivor, taking Revlimid and having quarterly Zometa infusions for bone strengthening. I have been thinking about having a conversation with my oncologist about is it necessary for me to continue my maintenance treatment. At the...
window with open journal and mug

Post-ASH: Reflections

Overall: As with every ASH, we are able to witness up close and personal the exciting advances in science and medicine – the research moving us more and more towards precision medicine, the current clinical trials (phases I, II, and III) and the medications approved...
falling gold glitter

Pre-conference Jitters

Excitement and a bit of trepidation are the emotions I would attribute to the eve of my third opportunity to attend the 64th American Society of Hematology Annual Meeting. I will attend virtually this year, as I did last year. There are quite a few of our Support...
nurse using tablet

How To Treat Myeloma? There Is No Easy Answer.

Attending the 64th American Society of Hematology (ASH) Annual Meeting, I am continually reminded of how far we have come in the treatment landscape of multiple myeloma (MM) since I became a nurse I 1991. Acronyms of drug regimens that, for the most part, are no...
myeloma cells

Not “One” Myeloma, Truly Multiple

There is so much information being produced and shared at the American Society of Hematology (ASH) Annual Meeting, it is challenging to digest it all and distill it down. In review of the many screen shots I took of the presentation slides, one piece of information...
Finding a hopeful future for myeloma patients reflected in nature's beauty.

Post-ASH Reflection: Hope

Hope is important because it can make the present moment less difficult to bear. If we believe that tomorrow will be better, we can bear a hardship today. –Thich Nhat Hanh  Reflecting on the opportunity I had to attend the 64th American Society of Hematology...
Myeloma blood sample

Patient Notes: A Consultant’s Guide to Smoldering Myeloma Session

Dr. Sigrun Thorsteinsdottir, MD, PhD, gave a comprehensive review of smoldering myeloma directed toward practitioners. The session was very informative and so I’d like to dedicate this blog to sharing this information from a patient’s perspective, as I’ll highlight...
Geometric illustration of multi coloured human figures

“Pre-ASH” ASH, Days 1 & 2

Hello Myeloma Community. It is time for an update from the 64th American Society of Hematology (ASH) Annual Meeting. Arriving on Thursday, I had the opportunity to spend time with my dear friend, Angela Dispenzieri as we walked around the French Quarter and took in...